Gene · 4751
Papers2,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-population genome-wide association study identifies multiple novel loci associated with asymptomatic intracranial large artery stenosis. | Int J Stroke | 2026 | 40851121 | PubTator, text mining | PubMed |
| USP7 promotes follicular thyroid carcinoma progression and sorafenib resistance by activating NEK2/ATG5-mediated autophagy. | Histol Histopathol | 2026 | 40838301 | PubTator, text mining | PubMed |
| Decoding Colorectal Cancer: Key Genes and Pathways in the Chinese Population Revealed. | Curr Med Chem | 2026 | 40183269 | PubTator, text mining | PubMed |
| Mutational insights and in silico characterization of NEK family kinases in OSCC patients from the Pakistani population. | Front Bioinform | 2025 | 41716219 | PubTator, text mining | PubMed |
| Integrative analysis reveals SRD5A2 as a central mediator in PPCPs induced modulation of the prostate cancer immune microenvironment. | Discov Oncol | 2025 | 41269424 | PubTator, text mining | PubMed |
| Integrated Expression Analysis May Support Serine/Threonine Kinases as Common Hub Genes in Breast Cancer. | Iran J Med Sci | 2025 | 41158841 | PubTator, text mining | PubMed |
| Integrative multidimensional analysis of age-associated synthetic lethal genes and development of a prognostic model in breast cancer. | Front Immunol | 2025 | 41112293 | PubTator, text mining | PubMed |
| TUFT1 regulates cancer progression by suppressing centrosome amplification and mitotic spindle multipolarity. | Cell Death Dis | 2025 | 41022752 | PubTator, text mining | PubMed |
Tumor microenvironment delineates differential responders to trastuzumab emtansine in HER2-positive metastatic breast cancer patients previously treated with pyrotinib: an exploratory biomarker analysis of a phase II study (NJMU-BC02). | Signal Transduct Target Ther | 2025 | 41016944 | PubTator, text mining | PubMed |
| Does microtubule motor-mediated centrosomal dyshomeostasis confer chemoresistance in breast cancer? | J Mammary Gland Biol Neoplasia | 2025 | 41003863 | PubTator, text mining | PubMed |
| [Expression of Concern] NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation. | Oncol Lett | 2025 | 40861104 | PubTator, text mining | PubMed |
| Harnessing free energy calculations for kinome-wide selectivity in drug discovery campaigns with a Wee1 case study. | Nat Commun | 2025 | 40858617 | PubTator, text mining | PubMed |
| Mechanism and cellular actions of the potent AMPK inhibitor BAY-3827. | Sci Adv | 2025 | 40845097 | PubTator, text mining | PubMed |
| Identification of biomarkers and potential therapeutic targets of breast cancer using bioinformatics analysis. | Medicine (Baltimore) | 2025 | 40826700 | PubTator, text mining | PubMed |
| Mitochondrial fission genes MTFP1/MTFP2 as predictive biomarkers in prostate cancer: a mendelian randomization study. | Discov Oncol | 2025 | 40824549 | PubTator, text mining | PubMed |
| Risk factors for multiple myeloma and its precursor diseases. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | 40785671 | PubTator, text mining | PubMed |
| Zinc finger protein 695 facilitates the proliferation of colorectal cancer cells through activation of the NEK2 and PI3K/Akt/mTOR signaling pathways. | Oncol Rep | 2025 | 40682845 | PubTator, text mining | PubMed |
| MCM4 as Potential Metastatic Biomarker in Lung Adenocarcinoma. | Diagnostics (Basel) | 2025 | 40564876 | PubTator, text mining | PubMed |
| Dynamic phosphorylation of MIS12 ensures accurate kinetochore-microtubule attachment by expanding the fibrous corona. | Mol Biol Cell | 2025 | 40560426 | PubTator, text mining | PubMed |
| Identification of a novel prognostic gene signature in pleural mesothelioma: a study based on The Cancer Genome Atlas database and experimental validation. | Transl Cancer Res | 2025 | 40530124 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4751/papers?page=3